Next we confirmed the role of TRPV2 in enhancing DOX-mediated effects by overexpressing TRPV2 in TNBC breast cancer cell line SUM159 and analyzed the drug uptake potential of these cells. The gene discussed is TRPV2; the disease is breast carcinoma.